News

Creating more value.
For doctors and patients

Information from science and research

Stay up to date!

Majority stake in HumanOptics AG to be sold to Chinese investor

Ad-hoc-Mitteilung gemäß Art. 17 MAR

Erlangen, August 30, 2019 - The Management Board of HumanOptics AG ("Company"), a leading technology company for the production of implants for eye surgery, was informed by its current majority shareholder Medipart AG, Unterägeri/Switzerland, ("Medipart") that Medipart signed a share purchase agreement to sell its stake of 73.4% in the share capital of the Company to a Chinese investor today. The closing of the sale is subject to the fulfillment to customary closing conditions, including approvals by Chinese public authorities.

End of the Ad-hoc-Disclosure

Contact:
HumanOptics AG
Investor Relations
Spardorfer Str. 150
91054 Erlangen
Telefon: +49 (0) 9131 50665-0
E-Mail: IR@humanoptics.com

Ad-hoc-Disclosure, 30.08.2019

Archive

HumanOptics international

Wichtige Messetermine

OUR

CUSTOMER SERVICE

YOUR

QUESTIONS

Our experts support you with your questions at any time.

    *Mandatory field

    Honored: CUSTOMFLEX® ARTIFICIALIRIS receives Prix Galien nomination

    News
    News

    The CUSTOMFLEX® ARTIFICIALIRIS has been nominated for the biomedical industry’s most prestigious award, the Prix Galien. The award honors the technical, scientific and clinical know-how underlying the development of innovative medicines and medical devices, such as the CUSTOMFLEX® ARTIFICIALIRIS. 1 The unique iris implant makes a major contribution to the quality of life of aniridia […]